Early-Stage HER2+ Breast Cancer

from Medical News Podcast · host PeerDirect Publishing

Drs. Lynce and Waks discuss advances in early-stage HER2+ breast cancer, focusing on how targeted therapies have transformed outcomes. They explore de-escalation strategies, the role of platinum drugs, insights from the COMPASS trial, and the importance of pathologic complete response in guiding treatment decisions.

Episode metadata supplied by the publisher feed · Published Oct 27, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Early-Stage HER2+ Breast Cancer

0:00 15:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 15 minutes long.

When was this Medical News Podcast episode published?

This episode was published on October 27, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!